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Abstract 
Short communication on YPEL3, with data on 
DNA/RNA, on the protein encoded and where the 
gene is implicated. 
Identity 
HGNC (Hugo): YPEL3 
Location: 16p11.2 
Local order: From telomere to centromere: 
MAPK3-GDPD3-LOC101928595-YPEL3-TBX6-
PPP4C-ALDOA-FAM57B-C16orf92-DOC2A. 
DNA/RNA 
Description 
YPEL3 has 4 exons. 
Transcription 
YPEL3 has 2 transcript variants, resulting from the 
differential processing of the exon 1. 
Transcript variant 1: 1588 bp mRNA (NCBI 
RefSeq NM_031477.4). 
Transcript variant 2: 940 bp mRNA (NCBI RefSeq 
NM_001145524.1). 
 
Local order of YPEL3 is shown together with leading and subsequent genes on chromosome 16. 
 
 
Boxes show exons; filled boxes correspond to coding exons, empty boxes indicate noncoding exons. Lines connecting the boxes 
represent introns. Arrows indicate the translation initiation codon. 
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Protein 
Note 
Two transcript variants encode two protein 
isoforms differing at their amino-termini. 
Protein yippee-like 3 isoform 1; 157 aa protein 
(NCBI RefSeq NP_113665.3). 
Protein yippee-like 3 isoform 2; 119 aa protein 
(NCBI RefSeq NP_001138996.1). 
Expression 
In human, YPEL3 is expressed in the brain, heart, 
kidney, lung, pancreas, placenta, skeletal muscle, 
colon, ovary, leukocyte, prostate, small intestine, 
spleen, testis, thymus, bone marrow, leukocyte, 
tonsil, fetal brain, fetal heart, fetal kidney, fetal 
liver, fetal lung, fetal skeletal muscle, fetal spleen 
and fetal thymus (Hosono et al., 2004). 
Localisation 
Immunofluorescence staining with an antibody 
recognizing Ypel1, 2, 3 and 4 proteins suggests that 
Ypel1-4 are nuclear proteins. In interphase cells, 
Ypel1-4 are localized in nucleoli and the 
centrosome. In the mitotic phase, Ypel1-4 become 
localized on or close to the mitotic apparatus rather 
than in the centrosome (Hosono et al., 2004). 
Function 
Studies show that the expression of YPEL3 gene is 
up-regulated during DNA damage, reflected as an 
increase in YPEL protein levels, likely through two 
functional p53 binding sites present on the YPEL3 
gene promoter (Kelley et al., 2010). 
When YPEL3 is expressed by a tetracycline 
inducible system at levels comparable to 
endogenous mRNA levels detected upon DNA 
damage, both MCF7 and U2OS cells showed fewer 
colonies compared to uninduced cells. YPEL3 
expressing U2OS and MCF7 cells also showed an 
increase in cellular senescence as shown by 
increases β-galactosidase activity and the 
appearance of foci within the nuclei of senescent 
cells (SAHF) (Kelley et al., 2010). 
Homology 
In human, YPEL3 has 4 paralogs; YPEL1, YPEL2, 
YPEL4 and YPEL5. Ypel3 has 88.2% aminoacid 
sequence identity with Ypel1; 89.1% with Ypel2; 
83.9% with Ypel4 and 43.8% with Ypel5 (Hosono 
et al., 2004). 
Ypel3 is an ortholog of Drosophila Yippee protein 
and has 45.5% aminoacid sequence identity to 
Yippee. There are 100 YPEL family genes in 68 
species including mammal, bird, amphibia, fish, 
protochordate, insect, nematode, coelenterate, 
echinoderm, protozoan, plant, and fungi. In this 
diverge range of organisms, YPEL family proteins 
show a high level of homology with many identical 
residues. Thus, a consensus sequence is deduced as 
follows: C-X2-C-X19-G-X3-L-X5-N-X13-G-X8-C-
X2-C-X4-GWXY-X10-K-X6-E. In the consensus 
sequence, the number of non-consensus residues, 
designated as X, is identical for all species 
examined (Hosono et al., 2004). 
Implicated in 
Colon cancer 
Note 
YPEL3 is found to be down-regulated in 9 
commercial colon tumor samples and in 22 patient 
colon adenocarcinoma (Tuttle et al., 2011). 
Ovarian cancer 
Note 
A significant decrease in YPEL3 mRNA levels was 
detected in 9 commercial and 30 patient ovarian 
tumors. In Cp70 ovarian cells, hypermethylation of 
a CpG island immediately upstream of the YPEL3 
promoter is suggested to be the basis for the 
observed down-regulation (Kelley et al., 2010). 
Lung cancer 
Note 
YPEL3 mRNA is shown to be down-regulated in 8 
of 9 commercial lung tumor samples (Tuttle et al., 
2011). 
Breast cancer 
Note 
YPEL3 is observed to be down-regulated in breast 
cancer cell models. Decrease in YPEL3 mRNA 
levels by siRNA causes an increase in the growth of 
estrogen receptor positive (ER+) MCF7 cells while 
YPEL3 over-expression decreases cell number. 
Moreover, YPEL3 mRNA as well as Ypel protein 
levels show an increase in MCF7 cells when 17β-
estradiol (E2) is withdrawn. In contrast, the 
addition of E2 at a circulating level (1nM) 
decreases the expression of YPEL3. The down-
regulation of YPEL3 by E2 can be reversed by the 
addition of selective estrogen receptor modulator, 
tamoxifen, TMX (Tuttle et al., 2012). 
In addition to p53, E2-ER signaling plays a role in 
the regulation of YPEL3 gene expression based on 
the observations that the reduction of intracellular 
ERa levels in MCF7 cells by ERa knockdown 
increases the expression of YPEL3 gene (Tuttle et 
al., 2012).  
Studies also showed that when grown in the 
absence of E2, MCF7 cells undergo cellular 
senescence, whereas the silencing of YPEL3 
rescues cells from senescence. Further evidence that 
YPEL3 is involved in E2-ER mediated cellular 
senescence was obtained from studies showing that 
the treatment of MCF7 cells with TMX increases 
the expression of the YPEL3 gene and that TMX-
induced cellular senescence is not observed when 
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YPEL3 is silenced. Importantly, cellular senescence 
induced by removal of E2 and/or over-expression 
of YPEL3 is independent of p53 expression.  
Thus, it appears that YPEL3 plays a role in E2-ER 
signaling dependent cellular growth and senescence 
in MCF7 cells.  
This in turn implies that Ypel3 is a tumor 
suppressor protein (Tuttle et al., 2012). 
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